GLP-1 Receptor Agonist and Bariatric Surgery Utilization Among Adolescents and Young Adults

Sarah E. Messiah; Deepali K. Ernest; Yaser Elnakieb; Subin Jang; Jackson M. Francis; M. Sunil Mathew; Luyu Xie; Bethany R. Cartwright; Faisal G. Qureshi; Jaime P. Almandoz; Sarah E. Barlow

doi:10.1001/jamapediatrics.2026.2828

July 20, 2026JAMA Pediatrics

GLP-1 Receptor Agonist and Bariatric Surgery Utilization Among Adolescents and Young Adults

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to understand the patterns of weight management strategies, including medication and surgery, among adolescents and young adults with obesity.
Cross-sectional study design
Target population: youths aged 13 to 25 years with obesity
Assessment of patterns in use for weight management medication, surgery, and combined therapy.
Identified varying patterns of GLP-1 receptor agonist use among participants
Documented the prevalence of bariatric surgery utilization in the age group
Showed the combination therapy of medication and surgery is emerging among youths with obesity.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

This cross-sectional study describes the pattern of use for weight management medication, surgery, and combined therapy among youths with obesity aged 13 to 25 years.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Messiah et al. (2026) studied this question.

synapsesocial.com/papers/6a605dd44163e025518d7cae https://doi.org/10.1001/jamapediatrics.2026.2828

View at Publisher

Ask AI

Bookmark

Share

GLP-1 Receptor Agonist and Bariatric Surgery Utilization Among Adolescents and Young Adults

Key Points

Ask about this paper

Abstract

Discussion

Cite This Study

GLP-1 Receptor Agonist and Bariatric Surgery Utilization Among Adolescents and Young Adults

Key Points

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading